Shaanxi Dongke Pharmaceutical Co., Ltd. (hereinafter referred to as "Dongke Pharmaceutical") is a high-tech enterprise integrating R&D, production and sales. The predecessor of Dongke Pharmaceutical was Yangling Dongke Madison Pharmaceutical Co., Ltd., which was established in Xian in 1993 and built a factory in Yangling in 1998. It was one of the first batch of key enterprises entering the zone in Yangling. In December 2014, Dongke Pharmaceutical joined Jichuan Pharmaceutical Group and became a wholly-owned subsidiary of the group, with total assets of 1 billion yuan and 400 employees. The company has 7 dosage forms and 40 national drug product groups covering the five core areas of respiration, pediatrics, gynecology, digestion, and orthopedics.
Jichuan Pharmaceutical Group is located in Taizhou City, Jiangsu Province. It is a national high-tech enterprise group integrating research and development, manufacturing, and commercial distribution of western medicine, traditional Chinese medicine cosmetics, and traditional Chinese medicine health products. It is a backbone enterprise in the national torch plan pharmaceutical industry and a national pharmaceutical company. Top 100 industrial enterprises, A-share listed company on the Shanghai Stock Exchange, stock code 600566.
In order to further expand production capacity, the company newly acquired 300 acres of land to build "Dongke Pharmaceutical Yangling Pharmaceutical Production Base" at No. 3 Zimao Street, Yangling Demonstration Zone. The total investment of the project is 1.5 billion yuan, and the total construction area is 290,000 square meters. The project is divided into two phases. Construction. The first phase of the project has an investment of 650 million yuan, a construction area of 130,000 square meters, and a designed production capacity of 1.5 billion yuan. Currently, it has obtained the production license qualification. It is a "scenic, garden-style, modern" pharmaceutical with advanced equipment and beautiful factory area. The enterprise has already stood on the land of Yangling and has become a new business card for biomedical enterprises in Yangling Demonstration Zone.
Since its establishment, Dongke Pharmaceutical has been recognized as a “National High-tech Enterprise, Shaanxi Enterprise Technology Center, Shaanxi Province Technological Innovation Demonstration Enterprise, Shaanxi Province Industrial Product Quality Control and Technology Evaluation Laboratory, and “Shaanxi Province Industrial Brand Cultivation Demonstration Enterprise ”, “Shaanxi Province Pharmaceutical Industry Advanced Group in Fighting New Coronary Epidemic”, the granulating team of solid preparation workshop was awarded “National Worker Pioneer”, and the company was awarded “Shaanxi Province Outstanding Private Enterprise, Shaanxi Province Quality Credit A Grade Enterprise, Shaanxi Province Advanced Safety Production "Unit" and other titles have been awarded "Yangling Economic Development Outstanding Contribution Award" for consecutive years; "Dongke" and "Yaowangshan" trademarks have been rated as well-known trademarks in Shaanxi Province, and the companys reputation and influence in the industry are increasing.
Dongke Pharmaceutical will rely on the Yangling area of the Shaanxi Free Trade Zone, leverage on the high-quality business and financing environment, and focus on the group company’s strategic plan of "three industries to advance together", actively deploy the big health industry, and strive to create a new biopharmaceutical industry in Yangling. Business card, strive to become a leading and well-known first-class pharmaceutical company in the province, and strive to achieve the goal of Healthy China 2030.